Shuttle Pharmactcls Hldgs Inc.
13F holders, Q1 2026 (March 31)8holders −1
2new positions
3sold out
$0.68avg. 13F price*
At the end of Q1 2026, 8 institutions reported holding Shuttle Pharmactcls Hldgs Inc. in their 13F filings, down 1 from Q4 2025. 2 opened new positions and 3 sold out. The largest holders were Ikarian Capital, LLC ($47K), Geode Capital Management, LLC ($31K) and Boothbay Fund Management, LLC ($14K).
- Company
- Shuttle Pharmactcls Hldgs Inc.
- CUSIP
- 825693401
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $8K |
| Exits | 3 | $28 |
All 13F filers, Q4 2025 → Q1 2026: 48,582 shares bought and 6,292 shares sold, net +42,290 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Ikarian Capital, LLC | 0.01% | No change | 68,993 | $47K |
| Geode Capital Management, LLC | 0.00% | Add +220.0% | 46,217 | $31K |
| Boothbay Fund Management, LLC | 0.00% | No change | 20,360 | $14K |
| Virtu Financial LLC | 0.00% | New | 12,380 | $8K |
| UBS Group AG | 0.00% | Reduce -52.5% | 5,670 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +471.6% | 4,641 | $3K |
| Kelleher Financial Advisors | 0.00% | New | 600 | $407 |
| Morgan Stanley | 0.00% | No change | 27 | $18 |
"% of holder's portfolio" is SHUTTLE PHARMACTCLS HLDGS IN's weight in each manager's 13F, not the share of Shuttle Pharmactcls Hldgs Inc. the manager owns.